Duterte Says Philippines Won't Oppose China on Sea Activity
(Bloomberg) -- Philippine's President Rodrigo Duterte reiterated that he would not provoke China into a war following reports that the Chinese military landed long-range bombers on an airport in the South China Sea.
“You know they have the planes, not stationed in Spratly but near the provinces facing -- Chinese provinces facing the Spratly and the China Sea. And with their hypersonic, they can reach Manila within seven to 10 minutes,” Duterte said in a speech on Saturday in Cebu, according to transcript emailed by his office Sunday.
Facing criticism over his apparent inaction on China's increasing military activity in the South China Sea, Duterte questioned where his country would end up should war erupt in the region. “What will we arm ourselves with if there's a war? Will we resort to slapping each other? I couldn't even buy myself a rifle. It was given to me. So how will we even fight with the Chinese?”
Duterte said there was no assurance that the U.S. would remain on the side of the southeast Asian nation if war broke out. A more feasible solution would be to forge a joint exploration pact with China to harness the disputed sea's potential, he said.
Senator Panfilo Lacson called on the Philippine's government on Saturday to act on China's militarization of the disputed waters. He said the Philippines could seek the help of its ally countries to pressure China to stop its military activities. It could also insist on the UN arbitration ruling won by the Philippines in July 2016.
To contact the reporter on this story: Ditas Lopez in Manila at dlopez55@bloomberg.net
To contact the editors responsible for this story: Stanley James at sjames8@bloomberg.net, John McCluskey
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.